Tag | Content |
---|
EnhancerAtlas ID | HS073-10036 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr3:4548950-4550540 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ESRRB | MA0141.3 | chr3:4548980-4548991 | TTTGACCTTGA | - | 6.14 | Esrra | MA0592.2 | chr3:4548981-4548992 | TTGACCTTGAA | - | 6.14 | RUNX1 | MA0002.2 | chr3:4549953-4549964 | GTCTGTGGTTT | + | 6.62 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_10644 | chr3:4542662-4550173 | CD19_Primary | SE_11257 | chr3:4533655-4563092 | CD20 | SE_13171 | chr3:4549224-4549951 | CD34_Primary_RO01480 | SE_13547 | chr3:4544776-4550219 | CD34_Primary_RO01536 | SE_14254 | chr3:4548954-4549892 | CD34_Primary_RO01549 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I004502 | chr3 | 4544126 | 4550060 |
|
Enhancer Sequence | AATAATGCCC CAATGTTATT GTGAAATAGT TTTGACCTTG AAGTTTCCCT GACCCTTGGG 60 CCACCAGCTC CTAGAGTACA TAGGTAATTT GAAATGTGGG GTTGTGGCAT GGAACATTAG 120 AGAGAGGGAG AAATTGAAGG CTTAAGTGAC AGGGTGCAAT TGACCATCTC TAAGTCTGGG 180 TATTGTATGA GATCTTTCTG TTCAGAAAAA AATGCATGGG GATACTTTTC AGTTGTTTTT 240 GTGAAACAAA ATTGCTTCCT AAAGTTCCTC CTGAAATGCA AAGAAACGCT GAGAATGTGG 300 AAGCTAGTGG TACTTGTCCT ACGTTCATCT TTTTCTTATG AGCAAGATTA TACCAAGCAG 360 TCCAGAAGTT CTGCAGTGGG ATGGGTCATT AAAAAATTAT AAAGCATAGG TTCCTCTCTG 420 TGTCTGAGAA TAGCAGCTTC AAGTGTAACT TCCTTTATAA CTGTTAGTCT CCAACACTTA 480 CTTTGTTCTT TTTGTAGCTT TTGGCCTCAG ATGAAGTTGT GTCCTACAAT AGAAATTAGA 540 TTGATGCTTA TTGCTCTTAG GTTCTGTCAT AACTGGTGTT TAAGGAACCA GGATAGAAGC 600 TTTTAATAAT AGATGAGCTA TATTCTGTGC TAGCCAGCTT CACTGTTTAA GGAGGTTAAA 660 TGATTACAAA TTCAGGCTTC TGGGGAGTGT TTTGCGTGTG TCTTGGGTCA GTGATATATA 720 AGATTTTCAC TGTTAAGGTA ATTGTGTGGT AAAATACAGA GGAGCTTGGT CATCAGGAAA 780 TTAATGGTGC ACTGTGGGGA CGAGGCGAGG GGTTGCAGGC AGGCAGGGGA TCCAAAGTAC 840 CTGACTCTCA TGCTCAGAAG GGTTTCATTT AAGGTCAGAC TGTCAGTGGG ACTACCCTGC 900 CACCCGATTA CTGAAAGTCA GACTGTTCAG CCCCAGTGGC CAGGTGGCTT CATCTTAATT 960 AAACGTAGGA GGCTTGCCTT TGTGTCTTGG TAAAAACTGG CAGGTCTGTG GTTTTGGGGT 1020 CCCTTAACTA GTATAAAGTC AATTTCTCAT TTCCTCCCAA GCCTGTCCAC CCTTGAAGAT 1080 TAAGTGATCC CTTAGGTAAC TTATTGGTTA ATGAAGTGTT CTACTTTAGT CTCAGTTTCA 1140 GGAGTTGTTA ACTTTTAAAT TCGGAATTCT GTGTAGGCGA AAATCAAGGT TTTTTTTTTT 1200 TTTTTTTTTT AAATGAATGT AATGCAATTA GTTAAGTGTG TGCAGGAGAA CTAATAGATG 1260 GAAAAATTTC AATAAGTGAG TTTTCTGCCA CAGTCAAATG AGTGAGTTTT CTATCACACT 1320 AAAAGCTTTT AGAAAAAAAA AAATTCCAAA CCTATCTTGA GCTGCTGCTT AAAATTAAAT 1380 GAACATATTT CTTTTTTAGT GAGGTTGTGC TTTGGCCTGT TTTAACACCA GAGTGGAAGA 1440 GGTTCTAAAT ACTGAATTAC TATCCCTTTG AAGAGGTTTC CACCACCCCC ACTGCCAGCA 1500 GGGGACCTAG ATTGATGTTA GAAGGCGGGG GAGTTGAGTT GAGGTCTGGC CAGCTTTGGT 1560 ATTGTGAGTT TGGGTACTGA AAAACAACAG 1590
|